Skip to main content
Erschienen in: World Journal of Urology 3/2015

01.03.2015 | Original Article

Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy

verfasst von: Sophie Hurel, Morgan Rouprêt, Thomas Seisen, Eva Comperat, Véronique Phé, Stéphane Droupy, François Audenet, Géraldine Pignot, Xavier Cathelineau, Laurent Guy, Olivier Cussenot, Adil Ouzzane, Gregory Bozzini, Laurent Nison, Alain Ruffion, Pierre Colin

Erschienen in: World Journal of Urology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the influence of preoperative factors on the survival of patients diagnosed with upper tract urothelial carcinoma (UTUC) who underwent a radical nephroureterectomy (RNU).

Methods

A multicentre retrospective study was performed on all patients with UTUC who underwent a RNU. Multiple preoperative criteria were tested as prognostic factors for cancer-specific survival (CSS) using univariate and multivariable Cox regression analyses.

Results

Overall, 476 patients with a median age of 69.2 (IQR 60.8–76.5) years were included. The median follow-up was 27.8 months (IQR 10.5–49.3). At the time of diagnosis, 400 (84.1 %) patients presented with symptoms and 76 patients (15.9 %) were asymptomatic. Renal failure, altered general health, a preoperative locally advanced tumour and multifocal disease appeared to be preoperative prognostic factors for CSS (p = 0.01, 0.03, 0.001 and 0.03, respectively) in the univariate analysis. Only renal failure (p = 0.03), a preoperative locally advanced tumour (0.004), and multifocal locations (p = 0.01) were confirmed as independent factors of CSS in the multivariate analysis. The independent prognosticators of definitive muscle-invasive stage and non-organ-confined disease were preoperative renal failure (p = 0.02, 0.027, respectively), locally advanced stage (p < 0.001, <0.001, respectively) and positive cytology (p = 0.006, 0.003 respectively). Female gender was independent factor only for prediction of final non-organ-confined disease (p = 0.007). The addition of these parameters in our preoperative complex model permitted the prediction of muscle-invasive or locally advanced disease in 65.3 and 67.2 % of patients, respectively.

Conclusions

Patients with preoperative impaired renal function, locally advanced stage and multifocal tumours before RNU had worse survival outcomes compared to other patients.
Literatur
1.
Zurück zum Zitat Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M et al (2012) Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer 48:456–464CrossRefPubMed Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M et al (2012) Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer 48:456–464CrossRefPubMed
2.
Zurück zum Zitat Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2010) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005. BJU Int 107:1059–1064CrossRefPubMed Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2010) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005. BJU Int 107:1059–1064CrossRefPubMed
3.
Zurück zum Zitat Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104:1436–1440CrossRefPubMed Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104:1436–1440CrossRefPubMed
4.
Zurück zum Zitat Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594–601CrossRefPubMed Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594–601CrossRefPubMed
5.
Zurück zum Zitat Bader MJ, Sroka R, Gratzke C, Seitz M, Weidlich P, Staehler M et al (2009) Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 56:65–71CrossRefPubMed Bader MJ, Sroka R, Gratzke C, Seitz M, Weidlich P, Staehler M et al (2009) Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 56:65–71CrossRefPubMed
6.
Zurück zum Zitat Matin SF, Margulis V, Kamat A, Wood CG, Grossman HB, Brown GA et al (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116:3127–3134CrossRefPubMed Matin SF, Margulis V, Kamat A, Wood CG, Grossman HB, Brown GA et al (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116:3127–3134CrossRefPubMed
7.
Zurück zum Zitat Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R et al (2011) Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the upper tract urothelial carcinoma collaboration. BJU Int 108:1286–1291CrossRefPubMed Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R et al (2011) Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the upper tract urothelial carcinoma collaboration. BJU Int 108:1286–1291CrossRefPubMed
8.
Zurück zum Zitat Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059–1071CrossRefPubMed Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059–1071CrossRefPubMed
9.
Zurück zum Zitat Roupret M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR et al (2013) Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. J Urol 189:1662–1669CrossRefPubMed Roupret M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR et al (2013) Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. J Urol 189:1662–1669CrossRefPubMed
10.
Zurück zum Zitat Sobin L, Godspodarowicz M, Wittekind C (2009) Renal pelvis and ureter. In: International Union Against Cancer (ed) TNM classification of malignant tumours. Urological tumours. Wiley, New York, pp 258–261 Sobin L, Godspodarowicz M, Wittekind C (2009) Renal pelvis and ureter. In: International Union Against Cancer (ed) TNM classification of malignant tumours. Urological tumours. Wiley, New York, pp 258–261
11.
Zurück zum Zitat Mostofi FK, Sorbin LH, Torloni H (1973) International histological classification of tumours: histological typing of urinary bladder tumours. World Health Organization ed Mostofi FK, Sorbin LH, Torloni H (1973) International histological classification of tumours: histological typing of urinary bladder tumours. World Health Organization ed
12.
Zurück zum Zitat Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116:2967–2973CrossRefPubMed Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116:2967–2973CrossRefPubMed
13.
Zurück zum Zitat Schips L, Lipsky K, Zigeuner R, Salfellner M, Winkler S, Langner C et al (2003) Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology 62:1024–1028CrossRefPubMed Schips L, Lipsky K, Zigeuner R, Salfellner M, Winkler S, Langner C et al (2003) Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology 62:1024–1028CrossRefPubMed
14.
Zurück zum Zitat Lee CT, Katz J, Fearn PA, Russo P (2002) Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 7:135–140CrossRefPubMed Lee CT, Katz J, Fearn PA, Russo P (2002) Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 7:135–140CrossRefPubMed
15.
Zurück zum Zitat Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M et al (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29:716–723CrossRefPubMed Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M et al (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29:716–723CrossRefPubMed
16.
Zurück zum Zitat Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ et al (2012) Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int 110:E7–E13. doi:10.1111/j.1464-410X.2011.10792.x CrossRefPubMed Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ et al (2012) Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int 110:E7–E13. doi:10.​1111/​j.​1464-410X.​2011.​10792.​x CrossRefPubMed
17.
Zurück zum Zitat Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F et al (2011) Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 60:1258–1265CrossRefPubMed Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F et al (2011) Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 60:1258–1265CrossRefPubMed
18.
Zurück zum Zitat Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M et al (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109:77–82CrossRefPubMedCentralPubMed Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M et al (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109:77–82CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A et al (2013) Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urol Oncol 31:1161–1165CrossRefPubMed Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A et al (2013) Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urol Oncol 31:1161–1165CrossRefPubMed
20.
Zurück zum Zitat Hung PH, Shen CH, Chiu YL, Jong IC, Chiang PC, Lin CT et al (2009) The aggressiveness of urinary tract urothelial carcinoma increases with the severity of chronic kidney disease. BJU Int 104:1471–1474CrossRefPubMed Hung PH, Shen CH, Chiu YL, Jong IC, Chiang PC, Lin CT et al (2009) The aggressiveness of urinary tract urothelial carcinoma increases with the severity of chronic kidney disease. BJU Int 104:1471–1474CrossRefPubMed
21.
Zurück zum Zitat Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112:453–461CrossRefPubMed Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112:453–461CrossRefPubMed
22.
Zurück zum Zitat Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69–73CrossRefPubMed Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69–73CrossRefPubMed
23.
Zurück zum Zitat Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y et al (2013) Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Ann Surg Oncol 20:4389–4396CrossRefPubMed Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y et al (2013) Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Ann Surg Oncol 20:4389–4396CrossRefPubMed
24.
Zurück zum Zitat Ito K, Kuroda K, Asakuma J, Hamada S, Tachi K, Tasaki S et al (2014) Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy. J Urol. doi:10.1016/j.juro.2013.12.048 Ito K, Kuroda K, Asakuma J, Hamada S, Tachi K, Tasaki S et al (2014) Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy. J Urol. doi:10.​1016/​j.​juro.​2013.​12.​048
25.
Zurück zum Zitat Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L et al (2010) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the surveillance, epidemiology, and end results database. Urology 75:321–327CrossRefPubMed Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L et al (2010) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the surveillance, epidemiology, and end results database. Urology 75:321–327CrossRefPubMed
26.
Zurück zum Zitat Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P et al (2014) Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature. Urol Oncol 32(54):e19–e26PubMed Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P et al (2014) Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature. Urol Oncol 32(54):e19–e26PubMed
Metadaten
Titel
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy
verfasst von
Sophie Hurel
Morgan Rouprêt
Thomas Seisen
Eva Comperat
Véronique Phé
Stéphane Droupy
François Audenet
Géraldine Pignot
Xavier Cathelineau
Laurent Guy
Olivier Cussenot
Adil Ouzzane
Gregory Bozzini
Laurent Nison
Alain Ruffion
Pierre Colin
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 3/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-014-1311-8

Weitere Artikel der Ausgabe 3/2015

World Journal of Urology 3/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.